The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes in patients with microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC) in the pre-immunotherapy era.
 
Koen Zwart
Research Funding - Bristol-Myers Squibb (Inst)
 
Frederieke van der Baan
No Relationships to Disclose
 
Matthew Dixon
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Bryan Frantz
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Cornelis J. A. Punt
Consulting or Advisory Role - Nordic Bioscience (Inst)
 
Miriam Koopman
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck Serono (Inst); Nordic Bioscience (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Bayer (Inst); Roche (Inst)
 
Geraldine R. Vink
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); SERVIER (Inst); Sirtex Medical (Inst)
 
Jeanine Roodhart
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); SERVIER (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Cleara Biotech (Inst); HUB Organoids (Inst); Merck Serono (Inst); Pierre Fabre (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - SERVIER (Inst)